ADEPTS: Accelerated Diagnosis of neuroEndocrine and Pancreatic TumourS

Medicine and Dentistry

1. Diagnosis 100%
2. Neuroendocrine Tumor 85%
3. Early Diagnosis 85%
4. Pancreas Cancer 60%
5. Malignant Neoplasm 60%
6. Pancreas Adenocarcinoma 51%
7. Pancreas Tumor 42%
8. Health Care Cost 42%
9. Cost-Effectiveness Analysis 34%
10. Patient 32%
11. Diabetes Mellitus 32%
12. Diagnostics 30%
13. Pancreatic Ductal Adenocarcinoma 25%
14. Biological Marker 24%
15. Secondary Care 21%
16. Therapeutic Procedure 17%
17. Symptom 17%
18. Inpatient 17%
19. Neoplasm 17%
20. Quality Adjusted Life Year 17%
21. Primary Health Care 14%
22. Surgery 12%
23. Health 12%
24. Adoption 8%
25. Pancreas 8%
26. Health Informatics 8%
27. Accuracy 8%
28. Blood Sampling 8%
29. Blood 8%
30. Endoscopy 8%
31. Disease 8%
32. Analysis 8%
33. Prevalence 8%
34. Survival 8%
35. Cancer Research 7%
36. High Risk Population 7%
37. Hyperglycemia 7%
38. Development 7%
39. Diagnostic Test 7%
40. Follow up 7%
41. Hemoglobin A1c 7%